Ronnie Pimentel, MD

877.463.2010

Ronnie Pimentel, MD

Appointed: 2006

Ronnie Pimentel, MD
Department: Gastroenterology and Hepatology Florida
Location: Florida, Weston
Mail Code WESTON
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:877.463.2010
DeskDesk:954.659.5646
WorkFax:954.659.5647
Surgeon:
No
Treats:
Adults Only

Education & Fellowships

Fellowship - Cleveland Clinic
Advanced Endoscopy
Cleveland, OH USA
1995
Fellowship - Cleveland Clinic
Gastroenterology
Cleveland, OH USA
1994
Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1992
Internship - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1990
Medical School - Universidad Nacional Pedro Henriquez Urena Escuela De Medicina
Santo Domingo Dominican Republic
1988

Certifications

  • Internal Medicine
  • Internal Medicine- Gastroenterology

Specialty Interests

Advanced Therapeutic Endoscopy, Endoscopic treatment of diseases of the bile ducts and pancreas, Endoscopic treatment of Gastrointestinal Cancer, Endoscopic treatment of Barrets Esophagus, Retrograde Cholangio Pancreatography (ERCP) Endoscopic Ultrasound (EUS) Endoscopic Mucosal Resection.

Awards & Honors

Olympus Advanced Endoscopy Scholarship 1994.

Memberships

  • Fellow, American College of Physicians
  • Fellow, American College of Gastroenterology
  • American Society for Gastrointestinal Endoscopy
  • American College of Gastroenterology

Treatment & Services

  • Argon Plasma Coagulation (APC)
  • Biliary And Pancreatic Stone Therapy
  • Cholangioscopy
  • Endoscopic Cancer Therapy
  • Endoscopic Dilation
  • Endoscopic Mucosal Resection
  • Endoscopic Retrograde Cholangiopancreatography
  • Endoscopic Treatment Of Strictures
  • Endoscopic Ultrasound
  • Enteral Stent Placement
  • Esophageal Band Ligation
  • Esophageal Dilation
  • Interventional Endoscopy
  • Pancreaticobiliary Endoscopy
  • Pyloric Dilatation
  • Sclerotherapy
  • Stents
  • Therapeutic Endoscopy
  • Variceal Band Ligation

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/13/2014, Dr. Pimentel has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Spanish
Cleveland Clinic Mobile Site